Home Ingredients Calcium Fructoborate (FruiteX-B®)
Joint HealthBone HealthAnti-Inflammatory

Calcium Fructoborate (FruiteX-B®)

Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Calcium fructoborate (CFB), marketed as FruiteX-B® by VDF FutureCeuticals, is a patented complex of calcium, fructose, and boron designed to mimic the boron-carbohydrate complexes naturally found in plant foods such as fruits and vegetables. Multiple human randomized controlled trials have evaluated CFB at 110–112 mg/day for knee discomfort, joint function, and systemic inflammation markers including C-reactive protein, IL-6, and IL-1β. The ingredient delivers a low daily dose of bioavailable boron with a documented safety profile and represents one of the more clinically substantiated boron supplements available, with effects observed at intakes comparable to dietary boron from a fruit-rich diet.

Studied Dose 110 mg twice daily (total ~2 mg boron/day) for knee comfort and joint function; 112 mg/day for inflammation markers; trials typically 14–90 days.
Active Compound Calcium fructoborate—a plant-mimetic complex of boron, fructose, and calcium delivering ~1.5–3 mg elemental boron per typical daily dose.

Benefits

Supports joint comfort

Daily intake has been shown in human trials to help reduce sensations of knee discomfort and improve pain and stiffness scores within 7–14 days, supporting comfortable joint movement during everyday activity.

Supported by Trial 1, Trial 2

Helps maintain healthy inflammation markers

Studies have observed reductions in circulating C-reactive protein and select inflammatory cytokines, indicating support for a balanced systemic inflammatory tone.

Supported by Trial 2

Promotes bone-friendly mineral status

Boron plays a supportive role in calcium and magnesium metabolism and steroid-hormone balance, helping maintain bone-supportive nutritional status.

Supported by Trial 1, Trial 2

Supports cardiometabolic markers

Some trials have observed favorable shifts in lipid markers and inflammatory cytokines, consistent with a role in supporting cardiovascular wellness as part of a healthy lifestyle.

Supported by Trial 2

Low-dose, plant-mimetic boron source

Delivers boron in a complex resembling natural plant boron-polyol structures, providing a well-characterized form of the trace mineral at intakes consistent with a fruit-rich diet.

Supported by Trial 1

Mechanism of action

1

Cytokine modulation

CFB intake has been associated with reductions in circulating CRP, IL-1β, IL-6, and MCP-1, suggesting modulation of pathways driving low-grade systemic inflammation.

2

Boron-mediated enzyme support

Boron supports activity of enzymes involved in steroid-hormone metabolism, vitamin D regulation, and matrix protein synthesis relevant to bone and joint health.

3

Mineral metabolism

Boron influences renal handling of calcium and magnesium and may help reduce calcium losses, contributing to mineral balance important for bone.

4

Antioxidant signaling

Preclinical work suggests boron-fructose complexes can support endogenous antioxidant defenses and reduce oxidative-stress markers.

Clinical trials

1
CFB for knee discomfort

Comparative double-blind, placebo-controlled trial, 110 mg CFB twice daily for 14 days

n=60 adults with knee discomfort

Participants taking CFB showed significant improvements in WOMAC and McGill Pain Questionnaire scores at day 7 and day 14 versus placebo, supporting rapid onset of joint-comfort benefits at a daily dose delivering ~2 mg boron.

2
CFB on inflammation and lipid markers

Double-blind, placebo-controlled trial, 112 mg/day CFB for 30 days

Adults with elevated inflammatory markers

The higher-dose CFB group showed substantial reductions in CRP (~31%), IL-1β (~29%), and MCP-1 (~31%) versus baseline, supporting CFB's ability to help maintain a balanced inflammatory tone.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated in trials at studied doses; mild GI upset occasionally reported.
Headache or transient fatigue rarely reported during initiation.
Boron has an established UL of 20 mg/day in adults; CFB doses are well below this threshold.
Not recommended during pregnancy at supplemental doses without medical supervision.
Allergic reactions are rare but possible in sensitive individuals.

Important Drug interactions

Estrogen-based therapies: boron may increase circulating estrogen levels modestly.
Magnesium and calcium supplements: additive effects on mineral status; usually beneficial but monitor.
Anticoagulants: no consistent interaction reported; monitor in high-risk patients.
Phosphate-binding medications: theoretical interaction via mineral metabolism.

More Joint Health Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Bone Health
Copper
Copper is an essential trace mineral and cofactor for over 30 enzymatic reactions, includi…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…
Anti-Inflammatory
Meriva® (Curcumin Phytosome — Indena)
Meriva® is a CURCUMIN PHYTOSOME® formulation developed by Indena (Italy) — using Indena's…

Explore Other Ingredients

Antioxidant
Curcumin/Turmeric
Curcumin, the primary bioactive compound in turmeric (Curcuma longa), is commonly suppleme…
Sleep Health
Serezin™
Serezin™ is PLT Health Solutions' patented blend of Boswellia serrata and ginger (Zingiber…
Muscle & Recovery
Bromelain
Bromelain is a proteolytic enzyme complex extracted from pineapple stem, widely used as a…

Frequently asked questions about Calcium Fructoborate (FruiteX-B®)

What is the recommended dosage of Calcium Fructoborate (FruiteX-B®)?

The clinically studied dose for Calcium Fructoborate (FruiteX-B®) is 110 mg twice daily (total ~2 mg boron/day) for knee comfort and joint function; 112 mg/day for inflammation markers; trials typically 14–90 days.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Calcium Fructoborate (FruiteX-B®) used for?

Calcium Fructoborate (FruiteX-B®) is studied for supports joint comfort, helps maintain healthy inflammation markers, promotes bone-friendly mineral status. Daily intake has been shown in human trials to help reduce sensations of knee discomfort and improve pain and stiffness scores within 7–14 days, supporting comfortable joint movement during everyday activity.

Are there side effects from taking Calcium Fructoborate (FruiteX-B®)?

Reported potential side effects may include: Generally well tolerated in trials at studied doses; mild GI upset occasionally reported. Headache or transient fatigue rarely reported during initiation. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does Calcium Fructoborate (FruiteX-B®) interact with medications?

Known drug interactions may include: Estrogen-based therapies: boron may increase circulating estrogen levels modestly. Magnesium and calcium supplements: additive effects on mineral status; usually beneficial but monitor. Consult a pharmacist or healthcare provider if you take prescription medications.

Is Calcium Fructoborate (FruiteX-B®) good for joint health?

Yes, Calcium Fructoborate (FruiteX-B®) is researched for Joint Health support. Daily intake has been shown in human trials to help reduce sensations of knee discomfort and improve pain and stiffness scores within 7–14 days, supporting comfortable joint movement during everyday activity.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Pietrzkowski Z, Phelan MJ, Keller R, Shu C, Argumedo R, Reyes-Izquierdo T. Short-term efficacy of calcium fructoborate on subjects with knee discomfort: a comparative, double-blind, placebo-controlled clinical study. Clin Interv Aging. 2014;9:895-9. doi: 10.2147/CIA.S64590.PubMedUsed to support: RCT in 60 adults with knee discomfort showing 110 mg CFB twice daily significantly improved WOMAC and McGill Pain scores by day 7 and day 14 versus placebo.
  2. Rogoveanu OC, Mogoşanu GD, Bejenaru C, Bejenaru LE, Croitoru O, Neamţu J, Pietrzkowski Z, Reyes-Izquierdo T, Biţă A, Scorei ID, Scorei RI. Effects of Calcium Fructoborate on Levels of C-Reactive Protein, Total Cholesterol, Low-Density Lipoprotein, Triglycerides, IL-1β, IL-6, and MCP-1: a Double-blind, Placebo-controlled Clinical Study. Biol Trace Elem Res. 2015;163(1-2):124-31. doi: 10.1007/s12011-014-0155-9.PubMedUsed to support: Double-blind placebo-controlled trial showing 112 mg/day CFB over 30 days reduced CRP by ~31%, IL-1β by ~29%, and MCP-1 by ~31% versus baseline, supporting effects on systemic inflammation markers.
  3. Scorei R, Mitrut P, Petrisor I, Scorei I. A Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Effect of Calcium Fructoborate on Systemic Inflammation and Dyslipidemia Markers for Middle-Aged People with Primary Osteoarthritis. Biol Trace Elem Res. 2011;144(1-3):253-63. doi: 10.1007/s12011-011-9083-0.PubMedUsed to support: Pilot RCT in middle-aged adults with primary osteoarthritis evaluating effects of calcium fructoborate on systemic inflammation and dyslipidemia markers, supporting joint-health and inflammatory-modulation positioning of CFB.